Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Total Non-Current Liabilities (2020 - 2022)

Sonoma Pharmaceuticals (SNOA) has 2 years of Total Non-Current Liabilities data on record, last reported at $11.9 million in Q3 2012.

  • For Q3 2012, Total Non-Current Liabilities rose 96.42% year-over-year to $11.9 million; the TTM value through Sep 2012 reached $11.9 million, up 96.42%, while the annual FY2012 figure was $6.7 million, 7.93% up from the prior year.
  • Total Non-Current Liabilities reached $11.9 million in Q3 2012 per SNOA's latest filing, up from $7.4 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $11.9 million in Q3 2012 and bottomed at $6.1 million in Q3 2011.